Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized Trial (English)
Free access
- New search for: Yadollahzadeh, Mahdi
- New search for: Nasiripour, Somayyeh
- New search for: Moradi Shahrbabak, Najmeh
- New search for: Rezaie, Nader
- New search for: Farrokhpour, Mohsen
- New search for: Azimi, Mehdi
- New search for: Izadi, Shirin
- New search for: Zamani, Farhad
- New search for: Farasatinasab, Maryam
- New search for: Diba, Hootan
- New search for: Yadollahzadeh, Mahdi
- New search for: Nasiripour, Somayyeh
- New search for: Moradi Shahrbabak, Najmeh
- New search for: Rezaie, Nader
- New search for: Farrokhpour, Mohsen
- New search for: Azimi, Mehdi
- New search for: Izadi, Shirin
- New search for: Zamani, Farhad
- New search for: Farasatinasab, Maryam
- New search for: Diba, Hootan
In:
Coronaviruses
;
5
, 1
;
53-58
;
2024
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized Trial
-
Additional title:COVID
-
Contributors:Yadollahzadeh, Mahdi ( author ) / Nasiripour, Somayyeh ( author ) / Moradi Shahrbabak, Najmeh ( author ) / Rezaie, Nader ( author ) / Farrokhpour, Mohsen ( author ) / Azimi, Mehdi ( author ) / Izadi, Shirin ( author ) / Zamani, Farhad ( author ) / Farasatinasab, Maryam ( author ) / Diba, Hootan ( author )
-
Published in:Coronaviruses ; 5, 1 ; 53-58
-
Publisher:
- New search for: Bentham Science Publishers Ltd.
-
Publication date:2024-02-01
-
Size:6 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 5, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Off-label Use of Medicines in COVID-19: A Lesson For FutureHemmati, Ali Asghar / Mojiri-Forushani, Hoda et al. | 2024
- 13
-
New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular Docking, Lipinski’s Rule and ADMET AnalysisRashid, Mohammad / Athar, Md Tanwir / Alazmi, Abdulrahman Salman / Kumar, Deepak / Kumar, Raj / Woo Lee, Keun / Alnami, Aisha et al. | 2024
- 53
-
Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized TrialYadollahzadeh, Mahdi / Nasiripour, Somayyeh / Moradi Shahrbabak, Najmeh / Rezaie, Nader / Farrokhpour, Mohsen / Azimi, Mehdi / Izadi, Shirin / Zamani, Farhad / Farasatinasab, Maryam / Diba, Hootan et al. | 2024
- 59
-
Enterococcal Infections: A Comparative Analysis between the Pandemic and the Pre-pandemic PeriodSharad, Neha / Srivastava, Smriti / Kiro, Vandana Vijayeta / Varma, Sharin / Srivastav, Sharad / Ningombam, Aparna / Malhotra, Rajesh / Mathur, Purva et al. | 2024
- 66
-
Polyherbal Syrup for Coronavirus Infection: Formulation and EvaluationKotta, Kranthi Kumar / Kadiri, Sunil Kumar / Gouru, Sampath Ayyappa et al. | 2024
- 74
-
Pandemic Preparedness for COVID-19: Research, Healthcare, and Pharmaceutical PerspectivesMani, Israel / Nandakumar, Manikandan Bilal / Balakrishnan, Amara Balan / Rahamathulla, Mohamudha Parveen / Pandi, Mohan et al. | 2024